Your browser doesn't support javascript.
loading
Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection - Surveillance for Emerging Threats to Mothers and Babies Network, 20 state, local, and territorial health departments, March 29, 2020 -January 8, 2021
Romeo R Galang; Suzanne M Newton; Kate R Woodworth; Isabel Griffin; Titilope Oduyebo; Christina L Sancken; Emily O'Malley Olsen; Kathy Aveni; Heather Wingate; Hanna Shephard; Chris Fussman; Zahra S Alaali; Samantha Siebman; Umme-Aiman Halai; Camille Delgado Lopez; Jerusha Barton; Mamie Lush; Paul H Patrick; Levi Schlosser; Ayomide Sokale; Ifrah Chaudhary; Bethany Reynolds; Similoluwa Sowunmi; Nicole Gaarenstroom; Jennifer S Read; Sarah Chicchelly; Leah de Wilde; Eduardo Azziz-Baumgartner; Aron J Hall; Van T Tong; Sascha Ellington; Suzanne M Gilboa; - CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team.
Afiliação
  • Romeo R Galang; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  • Suzanne M Newton; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  • Kate R Woodworth; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  • Isabel Griffin; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  • Titilope Oduyebo; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  • Christina L Sancken; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  • Emily O'Malley Olsen; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  • Kathy Aveni; Division of Family Health Services, New Jersey Department of Health, Trenton, New Jersey, USA
  • Heather Wingate; Communicable and Environmental Disease and Emergency Preparedness, Tennessee Department of Health, Nashville, Tennessee, USA
  • Hanna Shephard; Bureau of Family Health and Nutrition, Massachusetts Department of Public Health, Boston, Massachusetts, USA
  • Chris Fussman; Maternal and Child Health Epidemiology Section, Michigan Department of Health and Human Services, Lansing, Michigan, USA
  • Zahra S Alaali; Division of Epidemiology, New York State Department of Health, Albany, New York, USA
  • Samantha Siebman; Emerging Infections Program, Minnesota Department of Health, St. Paul, Minnesota, USA
  • Umme-Aiman Halai; Acute Communicable Disease Control Program, Los Angeles County Department of Public Health, Los Angeles, California, USA
  • Camille Delgado Lopez; Division of Children with Special Medical Needs, Puerto Rico Department of Health, San Juan, Puerto Rico, Puerto Rico
  • Jerusha Barton; Epidemiology Division, Georgia Department of Public Health, Atlanta, GA, USA
  • Mamie Lush; Division of Public Health, Nebraska Department of Health and Human Services, Lincoln, Nebraska, USA
  • Paul H Patrick; Perinatal and Reproductive Health Division, Oklahoma State Department of Health, Oklahoma City, Oklahoma, USA
  • Levi Schlosser; Division of Disease Control, North Dakota Department of Health, Bismarck, North Dakota, USA
  • Ayomide Sokale; Division of Maternal, Child and Family Health, Philadelphia Department of Public Health, Philadelphia, Pennsylvania
  • Ifrah Chaudhary; Division of Disease Prevention and Control, Houston Health Department, Houston, Texas, USA
  • Bethany Reynolds; Bureau of Epidemiology, Pennsylvania Department of Health, Pittsburgh, Pennsylvania, USA
  • Similoluwa Sowunmi; Center for Family Health, California Department of Public Health, Sacramento, California, USA
  • Nicole Gaarenstroom; Nevada High Sierra Area Health Education Center, Reno, Nevada, USA,
  • Jennifer S Read; Infectious Disease Epidemiology, Vermont Department of Health, Burlington, Vermont, USA and Larner College of Medicine
  • Sarah Chicchelly; Infectious Disease Epidemiology and Response, Kansas Department of Health and Environment, Topeka, Kansas, USA
  • Leah de Wilde; Epidemiology Division, US Virgin Islands Department of Health, Christiansted, St. Croix, United States Virgin Islands
  • Eduardo Azziz-Baumgartner; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  • Aron J Hall; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  • Van T Tong; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  • Sascha Ellington; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  • Suzanne M Gilboa; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  • - CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team; CDC COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Preprint em Inglês | medRxiv | ID: ppmedrxiv-21252169
ABSTRACT
BackgroundPregnant women with coronavirus disease 2019 (COVID-19) are at increased risk for severe illness compared with nonpregnant women. Data to assess risk factors for illness severity among pregnant women with COVID-19 are limited. This study aimed to determine risk factors associated with COVID-19 illness severity among pregnant women with SARS-CoV-2 infection. MethodsPregnant women with SARS-CoV-2 infection confirmed by molecular testing were reported during March 29, 2020-January 8, 2021 through the Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET). Criteria for illness severity (asymptomatic, mild, moderate-to-severe, or critical) were adapted from National Institutes of Health and World Health Organization criteria. Crude and adjusted risk ratios for moderate-to-severe or critical COVID-19 illness were calculated for selected demographic and clinical characteristics. ResultsAmong 5,963 pregnant women with SARS-CoV-2 infection, moderate-to-severe or critical COVID-19 illness was associated with age 30-39 years, Black/Non-Hispanic race/ethnicity, healthcare occupation, pre-pregnancy obesity, chronic lung disease, chronic hypertension, cardiovascular disease, and pregestational diabetes mellitus. Risk of moderate-to-severe or critical illness increased with the number of underlying medical or pregnancy-related conditions. ConclusionsPregnant women with moderate-to-severe or critical COVID-19 illness were more likely to be older and have underlying medical conditions compared to pregnant women with asymptomatic infection or mild COVID-19 illness. This information might help pregnant women understand their risk for moderate-to-severe or critical COVID-19 illness and inform targeted public health messaging. SummaryAmong pregnant women with COVID-19, older age and underlying medical conditions were risk factors for increased illness severity. These findings can be used to inform pregnant women about their risk for severe COVID-19 illness and public health messaging.
Licença
cc0
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
...